Skip to content

Clinical Comparison of Length of Cataract Procedures With Zeiss Lumera Versus Older Zeiss Microscope

Zeiss Lumera Microscope With Callisto Software

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03298841
Enrollment
50
Registered
2017-10-02
Start date
2017-03-01
Completion date
2017-09-20
Last updated
2021-04-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cataract

Brief summary

Study design will be a mix of retrospective (older Zeiss microscope previously in use at our surgery center) and prospective data collection with the Lumera and Callisto software. The Lumera and Callisto software system will be used for all cataract surgeries including toric analyses and lens placement.

Detailed description

Needs Assessment Research on this topic is needed as over 3 million cataract surgeries are performed in the United States each year. The number of surgeries performed is growing as baby boomers age. Reimbursements continue to decline, necessitating ever improving operating and surgical efficiencies in the operating room setting for physicians and small business owners to remain financially viable. New governmental regulations dictate that physician payments will be related to patient satisfaction and outcomes which may be better provided by newer and better surgical technologies. The Lumera operating microscope and Callisto software system provide several features that may enhance operating room flow including HD video screen and co-observant microscopes that can be independently adjusted to help operating room staff anticipate the needs of the surgeon. Enhanced retroillumination would be expected to translate into fewer complications and more confidence during surgery which could lead to less operating time, phaco energy used and improved visual outcomes. The toric alignment assistance device may lead to more accurate toric placement and improved visual outcomes after surgery. Target audience would include all cataract surgeons both high and lower volume. There is currently a dearth of published literature on this technology and its benefits in routine cataract surgery. There are no registered similar trials on Clinicaltrials.gov

Interventions

DEVICEZeiss

This study proposal will highlight the advanced technology features of the Zeiss Lumera surgical operating microscope which include but are not limited to: Stereo Coaxial Illumination for improved visualization High resolution video screen/co-observation tool to help OR staff anticipate next steps Integrated toric alignment tool Surgical microscope touch screen Cordless foot control for faster turnover between cases

Sponsors

Toyos Clinic
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 100 Years
Healthy volunteers
Yes

Inclusion criteria

* Visually significant cataract

Exclusion criteria

* Not visually significant cataract

Design outcomes

Primary

MeasureTime frameDescription
Improvement in Operating Room Efficiencies During Cataract Surgery With the Use of the New Lumera Operating Microscope Versus an Older Zeiss Model Operating Scopeduring surgery assessed up to one houroperating times during cataract surgery will be measured with the use of the new Lumera operating microscope versus an older Zeiss model operating scope by two experienced cataract surgeons in a single surgery center

Secondary

MeasureTime frameDescription
Number of Serious Adverse Events During Intra-operative and Post-operative Period6 weeksevents that are life or vision threatening, that require hospitalization or permanent disability of any type

Countries

United States

Participant flow

Participants by arm

ArmCount
Zeiss Group
patients undergoing uncomplicated phacoemulsification using Zeiss Lumera microscope with Callisto software
25
Leica Stativ S3B
patients undergoing uncomplicated phacoemulsification using Leica Stativ S3B microscope
25
Total50

Baseline characteristics

CharacteristicZeiss GroupLeica Stativ S3BTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
3 Participants2 Participants5 Participants
Age, Categorical
Between 18 and 65 years
22 Participants23 Participants45 Participants
Race and Ethnicity Not Collected0 Participants
Region of Enrollment
United States
25 participants25 participants50 participants
Sex: Female, Male
Female
15 Participants16 Participants31 Participants
Sex: Female, Male
Male
10 Participants9 Participants19 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 250 / 25
other
Total, other adverse events
0 / 250 / 25
serious
Total, serious adverse events
0 / 250 / 25

Outcome results

Primary

Improvement in Operating Room Efficiencies During Cataract Surgery With the Use of the New Lumera Operating Microscope Versus an Older Zeiss Model Operating Scope

operating times during cataract surgery will be measured with the use of the new Lumera operating microscope versus an older Zeiss model operating scope by two experienced cataract surgeons in a single surgery center

Time frame: during surgery assessed up to one hour

Population: patients undergoing uncomplicated phacoemulsification by two surgeons at one surgery site

ArmMeasureValue (MEAN)Dispersion
Zeiss GroupImprovement in Operating Room Efficiencies During Cataract Surgery With the Use of the New Lumera Operating Microscope Versus an Older Zeiss Model Operating Scope11.15 minutes per surgical procedureStandard Deviation 2.42
Leica Stativ S3BImprovement in Operating Room Efficiencies During Cataract Surgery With the Use of the New Lumera Operating Microscope Versus an Older Zeiss Model Operating Scope14.18 minutes per surgical procedureStandard Deviation 8.67
Secondary

Number of Serious Adverse Events During Intra-operative and Post-operative Period

events that are life or vision threatening, that require hospitalization or permanent disability of any type

Time frame: 6 weeks

Population: patients scheduled for routine cataract surgery with one of two experienced surgeons

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Zeiss GroupNumber of Serious Adverse Events During Intra-operative and Post-operative Period0 Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026